Yuzhuo Wang, Ph.D. FCAHS

Citata da

	Tutte	Dal 2019
Citazioni	23578	12124
Indice H	84	63
i10-index	207	181

2300

1150

575

1725

2002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202487 150 185 281 274 334 337 361 412 544 685 855 1031 1150 1429 1525 1546 1627 1797 2125 2151 2239 2157

Accesso pubblico

Visualizza tutto

164 articoli

9 articoli

Disponibili

Non disponibili

In base ai mandati di finanziamento

Coautori

Colin Collins, PhDProfessor of Urologic Sciences, University of British Columbia and Vancouver Prostate CentreEmail verificata su prostatecentre.com
Martin GleaveProfessor of Urologic Sciences, University of British ColumbiaEmail verificata su ubc.ca
Crea FrancescoProfessor of Cancer Pharmacology, The Open UniversityEmail verificata su open.ac.uk
Ladan Fazli MDUniversity of British Columbia - Vancouver Prostate CancerEmail verificata su prostatecentre.com
Simon W. HaywardDirector, Cancer Biology. NorthShore University HealthSystemEmail verificata su northshore.org
Himisha BeltranDana Farber Cancer InstituteEmail verificata su dfci.harvard.edu
Anne HaegertVancouver Prostate CentreEmail verificata su prostatecentre.com
Alexander WyattAssociate Professor, University of British ColumbiaEmail verificata su prostatecentre.com
Amina ZoubeidiUniversity of British ColumbiaEmail verificata su prostatecentre.com
Xinpei CiPrincess Margaret Cancer CentreEmail verificata su uhnresearch.ca
Stas VolikScientist, Vancouver Prostate CentreEmail verificata su prostatecentre.com
Abhijit ParoliaResearch Investigator & incoming Asst. Professor of Pathology, University of Michigan Medical SchoolEmail verificata su umich.edu
Mark A RubinProfessor & Director Department for BioMedical Research, University of BernEmail verificata su dbmr.unibe.ch
Robert H. BellVancouver Prostate CentreEmail verificata su prostatecentre.com
Takeshi KuritaTokyo Medical and Dental UniversityEmail verificata su tmd.ac.jp
Xuesen DongUniversity of British ColumbiaEmail verificata su prostatecentre.com
Gail RisbridgerMonash UniversityEmail verificata su monash.edu
Marianne SadarDistinguished Scientist, Michael Smith Genome Sciences Centre, BC Cancer Agency ProfessorEmail verificata su bcgsc.ca
David HuntsmanBC Cancer AgencyEmail verificata su bccancer.bc.ca
Shawn AndersonThe Vancouver Prostate Centre - UBC, VGHEmail verificata su prostatecentre.com

Segui

Yuzhuo Wang, Ph.D. FCAHS

Professor of Urologic Sciences, UBC

Email verificata su bccrc.ca - Home page

Prostate Xenograft PDX Therapeutic Development


Titolo Ordina per citazioni Ordina per anno Ordina per titolo	Citata da Citata da	Anno
Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets H Beltran, DS Rickman, K Park, SS Chae, A Sboner, TY MacDonald, ... Cancer discovery 1 (6), 487-495, 2011	998	2011
Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution P Eirew, A Steif, J Khattra, G Ha, D Yap, H Farahani, K Gelmon, S Chia, ... Nature 518 (7539), 422-426, 2015	672	2015
Regression of castrate-recurrent prostate cancer by a small-molecule inhibitor of the amino-terminus domain of the androgen receptor RJ Andersen, NR Mawji, J Wang, G Wang, S Haile, JK Myung, K Watt, ... Cancer cell 17 (6), 535-546, 2010	619	2010
Androgen receptor gene aberrations in circulating cell-free DNA: biomarkers of therapeutic resistance in castration-resistant prostate cancer AA Azad, SV Volik, AW Wyatt, A Haegert, S Le Bihan, RH Bell, ... Clinical cancer research 21 (10), 2315-2324, 2015	530	2015
Role of the stromal microenvironment in carcinogenesis of the prostate GR Cunha, SW Hayward, YZ Wang, WA Ricke Prostate and Renal Cancer, Benign Prostatic Hyperplasia, Erectile …, 2003	477	2003
The x cystine/glutamate antiporter: A potential target for therapy of cancer and other diseases M Lo, YZ Wang, PW Gout Journal of cellular physiology 215 (3), 593-602, 2008	464	2008
Malignant transformation in a nontumorigenic human prostatic epithelial cell line SW Hayward, Y Wang, M Cao, YK Hom, B Zhang, GD Grossfeld, ... Cancer research 61 (22), 8135-8142, 2001	423	2001
Hormonal, cellular, and molecular regulation of normal and neoplastic prostatic development GR Cunha, W Ricke, A Thomson, PC Marker, G Risbridger, SW Hayward, ... The Journal of steroid biochemistry and molecular biology 92 (4), 221-236, 2004	414	2004
High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug development D Lin, AW Wyatt, H Xue, Y Wang, X Dong, A Haegert, R Wu, S Brahmbhatt, ... Cancer research 74 (4), 1272-1283, 2014	409	2014
Cell differentiation lineage in the prostate Y Wang, SW Hayward, M Cao, KA Thayer, GR Cunha Differentiation 68 (4-5), 270-279, 2001	406	2001
The master neural transcription factor BRN2 is an androgen receptor–suppressed driver of neuroendocrine differentiation in prostate cancer JL Bishop, D Thaper, S Vahid, A Davies, K Ketola, H Kuruma, R Jama, ... Cancer discovery 7 (1), 54-71, 2017	384	2017
Cancer‐generated lactic acid: a regulatory, immunosuppressive metabolite? SYC Choi, CC Collins, PW Gout, Y Wang The Journal of pathology 230 (4), 350-355, 2013	363	2013
Role of stroma in carcinogenesis of the prostate GR Cunha, SW Hayward, YZ Wang Differentiation: REVIEW 70 (9‐10), 473-485, 2002	343	2002
Translational activation of HIF1α by YB-1 promotes sarcoma metastasis AM El-Naggar, CJ Veinotte, H Cheng, TGP Grunewald, GL Negri, ... Cancer cell 27 (5), 682-697, 2015	329	2015
Whole-exome sequencing of metastatic cancer and biomarkers of treatment response H Beltran, K Eng, JM Mosquera, A Sigaras, A Romanel, H Rennert, ... JAMA oncology 1 (4), 466-474, 2015	313	2015
YB-1 regulates stress granule formation and tumor progression by translationally activating G3BP1 SP Somasekharan, A El-Naggar, G Leprivier, H Cheng, S Hajee, ... Journal of Cell Biology 208 (7), 913-929, 2015	305	2015
Nkx3. 1 mutant mice recapitulate early stages of prostate carcinogenesis MJ Kim, R Bhatia-Gaur, WA Banach-Petrosky, N Desai, Y Wang, ... Cancer research 62 (11), 2999-3004, 2002	300	2002
The placental gene PEG10 promotes progression of neuroendocrine prostate cancer S Akamatsu, AW Wyatt, D Lin, S Lysakowski, F Zhang, S Kim, C Tse, ... Cell reports 12 (6), 922-936, 2015	279	2015
Prostatic hormonal carcinogenesis is mediated by in situ estrogen production and estrogen receptor alpha signaling WA Ricke, SJ McPherson, JJ Bianco, GR Cunha, Y Wang, GP Risbridger The FASEB journal 22 (5), 1512-1520, 2008	276	2008
MicroRNAs associated with metastatic prostate cancer A Watahiki, Y Wang, J Morris, K Dennis, HM O'Dwyer, M Gleave, PW Gout, ... PloS one 6 (9), e24950, 2011	275	2011

Il sistema al momento non può eseguire l'operazione. Riprova più tardi.

Articoli 1–20

Citazioni per anno

Citazioni duplicate

Citazioni unite

Aggiungi coautoriCoautori

Segui

Citata da

Coautori